Pain in patients with cerebral palsy (CP) is a major health issue strongly associated with
reduced quality of life. In this study, we provide an overview of pain conditions in children …

The introduction of botulinum toxin more than 25 years ago for the management of
paediatric lower and upper limb hypertonia has been a major advance. BoNT-A as a part of …

PURPOSE: Investigate the efficacy and safety of multipattern incobotulinumtoxinA injections
in children/adolescents with lower-limb cerebral palsy (CP)-related spasticity. METHODS …

There is no gold-standard treatment for idiopathic toe walking (ITW). Some previous
evidence suggested that botulinum neurotoxin-A injection might improve ITW. This is a …

IncobotulinumtoxinA, a pure botulinumtoxinA formulation, is free of accessory proteins. This
analysis provides pooled safety data from phase 3 trials of children/adolescents (2–17 …

Background: Cerebral Palsy (CP) is a group of permanent, but not unchanging, disorders of
movement and/or posture and motor function, which are due to a non-progressive …

Objective: To describe the current state of the art in the therapeutic administration of
botulinum toxin with indications, efficacy, and safety profile for children and adolescents with …

BACKGROUND: Cerebral palsy (CP) is the most common physical disability in childhood. It
is a heterogeneous condition in terms of etiology, motor type and severity of impairments …

Ботулинотерапия при детском церебральном параличе (ДЦП) рассматривается
сегодня не только как один из эффективных подходов для лечения повышенного …

Аннотация Введение. В настоящее время у пациентов с детским церебральным
параличом (ДЦП) ботулинотерапия применяется в лечении как нарушений мышечного …